Takao Yoshida

IFN-α Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity

T. Okazaki, T. Honjo, Tamon Hayashi, 2011, The Journal of Immunology.

Duration of T Cell-Mediated Immunity Death-1 Transcription and Limits the Directly Promotes Programmed Cell a IFN-HonjoTamon

T. Okazaki, Tamon Hayashi, S. Chikuma, 2011 .

Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer

K. Tsuta, Tomoko Yoshida, T. Kurata, 2021, BMC cancer.

PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo1

T. Okazaki, T. Honjo, Tamon Hayashi, 2009, The Journal of Immunology.

Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer

H. Sabe, S. Hirano, S. Hashimoto, 2021, Cell communication and signaling : CCS.

Investigation of the anti-tumor mechanism of tirabrutinib, a highly selective Bruton’s tyrosine kinase inhibitor, by phosphoproteomics and transcriptomics

Shingo Hotta, Y. Ariza, R. Kozaki, 2023, PloS one.

Vivo T Cell Anergy In + Production Induces CD 8 PD-1-Mediated Suppression of IL-2 Taku Okazaki and Tasuku Honjo

T. Honjo, Tamon Hayashi, S. Chikuma, 2009 .